Recommendations for Fully Vaccinated People
COVID-19 Homepage
Facility Readiness Assessment for Coronavirus Disease 2019 (COVID-19)
Infection Prevention and Control Considerations in Non-US Healthcare Settings
Strict implementation of infection prevention and control (IPC) measures at healthcare facilities during the COVID-19 pandemic will minimize healthcare-associated transmission of the virus that causes COVID-19 among healthcare workers (HCWs) and patients, and allow for ongoing provision of essential health services.
This tool has been developed for healthcare facilities and public health stakeholders in non-US healthcare settings to assess a facility’s readiness to identify and safely manage patients presenting with symptoms consistent with COVID-19, and to prepare for a surge of patients with COVID-19 during periods of widespread community transmission. A template work plan to address gaps identified during the assessment is provided at the end of the tool.
Facility name:
Date:
Coordination
Yes | No | N/A | Assessor Guidance | Assessor Comments | |
---|---|---|---|---|---|
Facility has an IPC focal person in place | |||||
Facility has an emergency response plan for COVID-19 or other viral respiratory pathogens in place | Ask to see a copy of the plan | ||||
Facility has an emergency committee that meets at least every week to discuss planning for and/or response to COVID-19 | Ask to see a copy of the last meeting’s minutes | ||||
Representative(s) from IPC participate in emergency committee meetings | Ask to see a copy of the last meeting’s minutes |
Communication and reporting
Yes | No | N/A | Assessor Guidance | Assessor Comments | |
---|---|---|---|---|---|
Facility has designated a focal person(s) available at all times to receive reports of suspected or confirmed COVID-19 cases | Ask for any documentation | ||||
HCWs have been given phone number(s) for focal person(s) available at all hours to report suspected or confirmed COVID-19 cases | Ask HCWs to provide focal person phone number(s) | ||||
COVID-19 focal person(s), facility leadership, and/or emergency committee know public health authorities at national or sub-national level to report suspected or confirmed COVID-19 cases | Ask facility to describe reporting process | ||||
COVID-19 focal person(s) and facility leadership know national or sub-national guidance for referring patients with suspected or confirmed COVID-19 for treatment (home care for mild cases, refer to treatment center for moderate to severe cases, etc.) | Select N/A if no guidance exists. If guidance exists, asks facility to describe plans for managing or referring patients for treatment. |
Supplies
Yes | No | N/A | Assessor Guidance | Assessor Comments | |||
---|---|---|---|---|---|---|---|
Facility is able to estimate its consumption rate (supply used per week) for critical supplies, including PPE, hand hygiene supplies, and disinfection materials | Ask facility to provide consumption rate estimates | ||||||
Facility performs an inventory of PPE supply at least once a month | Ask facility to provide results of most recent inventory | ||||||
A person responsible for managing the supply chain for critical IPC supplies has been identified | Ask facility to identify IPC supply chain point of contact | ||||||
Facility leadership knows how to request additional supplies from national or sub-national authorities | Ask about procurement chain | ||||||
Additional considerations for supplies in locations with community transmission: | |||||||
Facility has performed an inventory of PPE supplies in the past 7 days | Ask facility to provide results of most recent inventory | ||||||
Facility has the following supplies in stock in any amount at the time of the assessment: | Note any items in low supply in comments | ||||||
Non-sterile gloves | |||||||
Gowns | |||||||
Aprons | |||||||
Eye protection (face shields or goggles) | |||||||
Face masks | |||||||
N95, FFP2, or equivalent respirators | For aerosol generating procedures | ||||||
Alcohol-based hand rub | |||||||
Soap | |||||||
Hospital-grade disinfectants (e.g., sodium hypochlorite) | WHO recommends 0.5% chlorine for disinfecting surfaces |
Training
Yes | No | N/A | Assessor Guidance | Assessor Comments | |
---|---|---|---|---|---|
All HCWs (including clinical and support staff) are trained in recognition of COVID-19 symptoms | Ask facility to provide documentation of training; look for job aids, etc. | ||||
HCWs who will be working in areas evaluating or treating patients with suspected and confirmed COVID-19 are trained in standard and transmission-based precautions in the context of COVID-19 | This includes clinical and non-clinical staff. Training should include donning and doffing of PPE. | ||||
Cleaners are trained in cleaning rooms or areas occupied by patients with suspected or confirmed COVID-19 | Ask facility to provide documentation of training |
Triage and evaluation of suspected COVID-19 cases
Yes | No | N/A | Assessor Guidance | Assessor Comments | |
---|---|---|---|---|---|
Facility is implementing alternative ways for patients seeking care with respiratory symptoms to communicate before presenting to the facility, such as a telephone hotline or other communication system | Ask facility to describe hotlines, telemedicine, other communication modalities | ||||
Signs or posters directing patients with respiratory symptoms to proceed directly to the registration desk are posted at all facility entrances | Identify all entrances to ensure that guidance is posted | ||||
A physical barrier is in place between staff and patients presenting to the registration desk (for example, a plastic/glass window or table providing at least 1 meter separation) | Registration staff should be protected from any patient respiratory secretions | ||||
Facility has created a separate area for patients presenting with acute respiratory symptoms (the “respiratory waiting area”) | This area should be well-ventilated | ||||
Benches, chairs, or other seating in the respiratory waiting area is separated by at least 1 meter | |||||
Single rooms with doors are available for physical evaluation of patients with respiratory symptoms | |||||
If single rooms are not available, a well-ventilated, private area away from other patients is available for conducting physical evaluations | For general ward rooms with natural ventilation, WHO recommends 60 L/s per patient | ||||
COVID-19 triage forms and/or flow chart are available for HCWs evaluating patients in the respiratory waiting area | Should be provided by Ministry of Health or other national body | ||||
HCWs conducting physical evaluations of patients with respiratory symptoms have access to gowns, gloves, face masks, and eye protection | |||||
Plans exist for the safe transfer of patients with suspected or confirmed COVID-19 identified during triage process to inpatient care units or to other designated facilities | Mild cases may be discharged home (based on local guidance) | ||||
Additional considerations for triage in locations with community transmission: | |||||
Facility has increased staff dedicated to triage for COVID-19 to minimize overcrowding in the respiratory waiting area | |||||
Facility has identified a separate ancillary or temporary structure to serve as additional space for patients with fever and respiratory symptoms to be evaluated | Such as tents, drive-through testing centers, fever clinics, etc. |
For facilities providing care to patients with suspected or confirmed COVID-19
Yes | No | N/A | Assessor Guidance | Assessor Comments | |
---|---|---|---|---|---|
Gowns, gloves, face masks, respirators, and eye protection are available for all units providing care to patients with suspected or confirmed COVID-19 | PPE should be located outside entrance to unit | ||||
Patients with suspected or confirmed COVID-19 are housed in single rooms | |||||
If single rooms are not available, patients with suspected or confirmed COVID-19 are cohorted in a well-ventilated area | For general ward rooms with natural ventilation, WHO recommends 60 L/s per patient | ||||
Facility has an airborne infection isolation room or other adequately ventilated room for performing aerosol generating procedures | WHO recommends at least 160 L/s per patient in rooms with natural ventilation or 12 air changes per hour in rooms with mechanical ventilation | ||||
N95, equivalent, or higher-level respirators are available for HCWs performing aerosol generating procedures | Should be available outside of the procedure room |
Monitoring HCWs and inpatients for COVID-19
Yes | No | N/A | Assessor Guidance | Assessor Comments | |
---|---|---|---|---|---|
Facility has plan in place for monitoring of HCWs exposed to patients with COVID-19 | This may vary based on local epidemiology of COVID-19 (self-monitoring or active monitoring). Provide details in comments. | ||||
Facility has a policy in place for determining when HCWs with suspected or confirmed COVID-19 may return to work | This may be based on a national/sub-national document or a local/facility-level policy | ||||
Facility has a process to identify inpatients with COVID-19 symptoms | Ask facility to describe process. This could range from training clinicians to report suspicious cases to formal surveillance; plan should include reporting to facility leadership and public health. |
Preparing for a surge of patients with COVID-19
Yes | No | N/A | Assessor Guidance | Assessor Comments | |
---|---|---|---|---|---|
Facility knows its maximum capacity in the event of a surge (to be based on availability of physical space, human resources, intensive care capabilities, ventilator support, etc.) | Review plans for increasing capacity in a surge situation | ||||
Facility has developed a plan to stop non-essential services (e.g., elective or non-urgent procedures) in the event of a surge | Should be done in coordination with national, sub-national, and/or local authorities | ||||
Facility has identified additional space that can be used to expand the number of patients that can be treated (assuming adequate human resources, supplies, etc. are available) | |||||
Facility has developed a plan to move non-critical patients elsewhere (e.g, home, long-term care facilities) to increase capacity in the event of a surge | Should be done in coordination with national, sub-national, and/or local authorities | ||||
Facility has estimated consumption rates for critical supplies, including PPE, in the context of a surge scenario |
Work plan to address gaps
At the end of the assessment, the assessor and facility participants should review the tool and identify all items recorded as “No.” The facility, in collaboration with the assessor, should prioritize these items based on ease of addressing each gap, the availability of resources to address gaps (including partner support, human resources, financial resources, etc.), and the local epidemiological situation. Priority gaps and activities to address them should be recorded in the work plan below, along with a person(s) responsible for implementing the activities and a timeline for implementation.
Gap identified | Activities to address gap | Who is responsible? | Timeline |
---|---|---|---|